Literature DB >> 26226472

Periprosthetic Tissue Loss in Patients With Idiopathic Vitreous Inflammation After the Boston Keratoprosthesis.

Christina M Grassi1, Andrea Cruzat, Elise V Taniguchi, Alja Crnej, Kathryn A Colby, Claes H Dohlman, James Chodosh.   

Abstract

PURPOSE: Idiopathic vitritis is a poorly understood complication after Boston keratoprosthesis surgery with unclear etiology. We sought to determine whether an association exists between periprosthetic corneal tissue loss and the development of idiopathic vitritis in keratoprosthesis recipients.
METHODS: Thirteen Boston type I keratoprosthesis recipient eyes with a history of idiopathic vitritis and 34 type I keratoprosthesis recipient eyes with no history of idiopathic vitritis underwent anterior segment optical coherence tomography (AS-OCT) at a median time postoperatively of 2.4 years versus 1.9 years (range, 0.5-14.2 vs. 0.1-13.6 years), respectively. Areas of corneal graft tissue loss ("gaps") around the keratoprosthesis stem were identified and analyzed by 2 masked observers. The difference in the presence, number, and size of gaps was compared between cases and controls.
RESULTS: A periprosthetic gap was identified more commonly in idiopathic vitritis cases than in controls on AS-OCT (11/13, 86% vs. 11/34, 33.3%, P < 0.001). The number of gaps between cases and controls was also significantly different (2.6 ± 1.6 vs. 0.5 ± 0.8, P < 0.001), but not the estimated gap area (0.056 ± 0.049 mm² vs. 0.039 ± 0.025 mm², P = 0.22).
CONCLUSIONS: A significantly higher proportion of keratoprosthesis recipient eyes with idiopathic vitritis had corneal tissue loss around the keratoprosthesis stem than did controls. Tissue loss could serve as an entry point for debris or bacterial components, triggering idiopathic vitritis. Our study underscores the utility of AS-OCT imaging in the postoperative management of keratoprosthesis patients.

Entities:  

Mesh:

Year:  2015        PMID: 26226472     DOI: 10.1097/ICO.0000000000000557

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  3 in total

Review 1.  [Treatment of vascularized high-risk eyes with a Boston keratoprosthesis].

Authors:  F Schaub; M Matthaei; P Enders; S Siebelmann; D Hos; B O Bachmann; C Cursiefen
Journal:  Ophthalmologe       Date:  2021-03-17       Impact factor: 1.059

Review 2.  Keratoprosthesis: Current global scenario and a broad Indian perspective.

Authors:  Geetha Iyer; Bhaskar Srinivasan; Shweta Agarwal; Deepti Talele; Ekta Rishi; Pukhraj Rishi; Sripriya Krishnamurthy; Lingam Vijaya; Nirmala Subramanian; Shanmugasundaram Somasundaram
Journal:  Indian J Ophthalmol       Date:  2018-05       Impact factor: 1.848

3.  Clinical Experience in Patients with Ocular Burns Treated with Boston Type I Keratoprosthesis Implantation with or Without Prophylactic Ahmed Glaucoma Valve Implantation.

Authors:  Jianjun Gu; Yuying Zhang; Jiajie Zhai; Lixia Lin; Zhancong Ou; Ting Huang; Miao Chen; Jin Zhou; Liangbo Zeng; Yuwei Xu; Jiaqi Chen
Journal:  Ophthalmol Ther       Date:  2021-12-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.